AI Will Not Replace Doctors, But Doctors Using AI Will Replace Those Who Don't, Says AIG Hospitals Chairman
核心洞察
Dr. D Nageshwar Reddy of AIG Hospitals stated that AI will augment rather than replace physicians, with AI-proficient doctors replacing those who resist the technology.
AI has accelerated drug discovery timelines from decades to approximately two years, with major changes expected in pharmaceutical research over the coming decade.
AIG Hospitals deployed AI systems including MIRA for patient assistance and iSAVE for early warning of patient deterioration, reducing surgery dropout rates from 20% to 1%.
Artificial Intelligence will not replace doctors, but physicians who effectively use the technology will replace those who do not, according to Dr. D Nageshwar Reddy, Chairman of AIG Hospitals. Speaking on July 3 at the 16th Foundation Day Lecture of the ICFAI Foundation for Higher Education (搜索) in Hyderabad, Reddy delivered an address titled "Artificial Intelligence and the Future of Healthcare," asserting that AI has the potential to transform healthcare by making it more accessible, affordable, and efficient.
Reddy emphasized that medicine has always combined empathy and human intelligence, and AI should be viewed as a tool to augment healthcare professionals rather than replace them. "AI will not replace doctors, but doctors who know how to use AI will replace those who don't," he said, noting that many physicians remain hesitant to adopt AI due to fears of being replaced.
AI in Drug Discovery and Clinical Applications
According to Reddy, AI has significantly accelerated drug discovery, reducing development timelines from decades to about two years. He predicted that the coming decade is expected to witness major changes in pharmaceutical research. AI is increasingly being deployed across healthcare in areas such as drug discovery, radiology, telemedicine, precision medicine, predictive medicine, genomics, cancer detection, dermatology, and remote patient monitoring.
Real-World AI Deployments at AIG Hospitals
Citing examples from AIG Hospitals, Reddy highlighted several AI-powered systems developed and deployed at the institution. MIRA (Medical Information Robotic Assistant) is an AI-powered system that assists doctors and nurses, answers patient queries, reduces consultation waiting time, and supports medical education.
The hospital also developed iSAVE, an AI-based early warning system that continuously monitors critically ill patients and alerts doctors nearly an hour before a patient's condition deteriorates, allowing timely intervention. Reddy noted that AI had also helped redesign the hospital's pre-anaesthesia evaluation process by recommending a centralized pre-surgery lounge instead of requiring patients to move between multiple testing stations. This change reduced patient fatigue and brought down surgery dropout rates from nearly 20 percent to about one percent.
Additionally, AI supports management of the hospital's high-volume endoscopy services, where nearly 700 procedures are performed daily.
Addressing Disease Burden Through AI
Reddy highlighted that AI could help tackle India's growing burden of fatty liver disease (搜索) by enabling affordable screening using a few simple clinical parameters instead of expensive diagnostic tests. AI-powered analysis of CT scans is also improving early cancer detection, while wearable devices equipped with AI are enabling continuous health monitoring and early warning of illnesses.
AI-enabled clinical documentation systems can automatically generate medical summaries from doctor-patient conversations, allowing physicians to spend more time interacting with patients. AIG Hospitals also aims to develop interoperable medical records that can eventually be shared seamlessly across hospitals, Reddy added.
Ethical Considerations and Future Outlook
While AI is often perceived as lacking compassion, studies indicate that AI-supported systems can improve patient engagement and communication, Reddy said. He stressed that issues related to data quality, ethics, privacy, and regulation must be addressed as AI adoption expands.
Concluding his lecture, Reddy said AI has the potential to democratize healthcare by extending quality medical services to millions who currently lack access, provided it is adopted responsibly and ethically.
ICFAI Chancellor Dr. C Rangarajan, who presided over the function, noted that AI technology was still in its infancy and its long-term impact remained uncertain. He stressed that future innovations should make healthcare more affordable and ensure that the benefits of AI reach all sections of society.